• Nosocomial Pneumonia
• Community-acquired Pneumonia
• Complicated Intra-abdominal Infections
• Complicated Urinary Tract Infections
• Intra- And Post-partum Infections
• Complicated Skin Infections

Indications:

• Excellent activity against a broad range of bacteria including many potntially resistant strains such as Pseudimonas aeruginosa
• Shows higher clinical efficacy rates than imipenem/cilastatin in complicated skin and soft tissue Infections¹
• Satisfactory response in 100% of patients in treatment of community-acquired pneumonia²
• Favourable and acceptable safety profile³